-
Romidepsin, sold
under the
brand name Istodax, is an
anticancer agent used in
cutaneous T-cell
lymphoma (CTCL) and
other peripheral T-cell
lymphomas (PTCLs)...
-
Docetaxel Larotaxel Pa****axel
Taxotere Tesetaxel Ixabepilone Entinostat Romidepsin Vorinostat Zabadinostat Belotecan Camptothecin Exatecan Gimatecan Irinotecan...
-
Vorinostat (Zolinza) a
hydroxymate histone deacetylase (HDAC)
inhibitor (2009)
Romidepsin (Istodax) a
cyclic peptide histone deacetylase (HDAC)
inhibitor (2018)...
-
cyclic tetrapeptides (such as
trapoxin B, and the depsipeptides, such as
romidepsin,
bocodepsin hydrochloride benzamides,
electrophilic ketones, and the aliphatic...
- in
October 2006 for the
treatment of
cutaneous T cell
lymphoma (CTCL).
Romidepsin (trade name Istodax) was
licensed by the US FDA in Nov 2009 for cutaneous...
-
Panobinostat Parthenolide Phenylbutyrate Pracinostat Quisinostat Resminostat Romidepsin Scriptaid Sodium butyrate Sodium oxybate (GHB sodium)
Sodium phenylbutyrate...
-
effects involving the skin. It is only
available at a few institutions.
Romidepsin,
vorinostat and a few
others are a second-line drug for
cutaneous T-cell...
- 5-azacytidine,
romidepsin and
other DMNT
inhibitors (i.e. 5-azacytidine, hydralazine, 5-Aza-2’-deoxycytidine) and HDAC
inhibitors (i.e.
romidepsin, belinostat...
- (USAN)
rolziracetam (INN)
romazarit (INN)
Romazicon romergoline (INN)
romidepsin (USAN)
romifenone (INN)
romifidine (INN)
Romilar AC
romiplostim (USAN)...
-
correlated with the
reduction of DNA
repair enzymes (Garcia et al., 2008).
Romidepsin, a drug in
phase two
clinical trials, has
demonstrated higher efficacy...
